Interventional effect of atorvastatin on inflammatory factors hs-CRP,TNF-αand IL-6 of coronary heart disease
- VernacularTitle:阿托伐他汀对冠心病炎症因子hs-CRP、TNF-α和IL-6水平的干预作用
- Author:
Yuanyuan JI
;
Gang LI
;
Zhiyuan LIU
;
Yudong LI
;
Xisheng ZHENG
;
Mei CHENG
- Publication Type:Journal Article
- Keywords:
atorvastatin;
coronary heart disease;
inflammatory factors
- From:
Chinese Journal of Biochemical Pharmaceutics
2014;37(7):147-149
- CountryChina
- Language:Chinese
-
Abstract:
Objective To explore the effects of atorvastatin on inflammatory factors(hs-CRP,TNF-αand IL-6 levels )of coronary heart disease. Methods 160 patients with coronary artery disease were selected which were treated in Nanyang Municipal Central Hospital from January 2010 to July 2014.The 160 CHD patients were divided into two groups using the random number table method.On the basis of conventional treatment,patients of the experimental group were given atorvastatin,but the patients of control group were given only the other conventional treatment.Patients of two groups were tested about inflammatory factors before treatment and after two months treatment,and then analyzed and compared.Results It had no statistically significant difference on hs-CRP,TNF-αand IL-6 levels in patients of the two groups before treatment;it had statistically significant difference on hs-CRP,TNF-αand IL-6 levels in patients of the two groups of two months after treatment(P<0.05 );differences on hs-CRP,TNF-αand IL-6 levels of patients between pre-treatment and after treatment of two months in the experimental group were statistically significant (P<0.05 );however,it was opposite in the control group.Conclusion Atorvastatin could significantly reduce the levels of inflammatory factors(hs-CRP、TNF-αand IL-6)of patients with coronary artery disease.It has important clinical value.
